The impact of the COVID-19 pandemic means that hundreds of trials have been affected—including delays and disruptions to ongoing trials and cancellations or revisions to planned ones—and more changes are expected.
It is apparent the pandemic will have a far-reaching impact on clinical trials, which will ripple out to all areas of the healthcare industry.
AVENIR GLOBAL, a powerhouse firm of specialist communications agencies, is uniquely positioned to think through every one of these aspects, drawing upon expertise in clinical trial recruitment and retention, medical communications to educate HCPs, public relations, internal communications, patient communications, launch preparation, public affairs and market access.
Drawing upon this deep experience and expertise, the Firm has today launched the Ripple Effect, a curated selection of resources on the impact of COVID-19 on the clinical trial space.
The site has been designed to be a practical resource containing timely insights from our multi-disciplinary group of in-house industry experts on the short, medium and longer-term impact of COVID on the clinical trial space.
Content on the site will constantly evolve to stay ahead of the ever-changing environment, enabling clients to make informed decisions within their specific functions and companies as the situation develops.
Click here to explore the Ripple Effect site.